Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox-Reference-Cited by-同舟云学术

Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox

Published:2019-07-17 Issue:10 Volume:42 Page:1028-1040
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Ahrens Ingo¹,Averkov Oleg²,Zúñiga Eduardo C.³,Fong Alan Y. Y.⁴,Alhabib Khalid F.⁵,Halvorsen Sigrun⁶,Abdul Kader Muhamad A. B. S. K.⁷,Sanz‐Ruiz Ricardo⁸,Welsh Robert⁹,Yan Hongbin¹⁰,Aylward Philip¹¹^ORCID

Affiliation:

1. Augustinerinnen Hospital, Academic Teaching HospitalUniversity of Cologne Cologne Germany

2. Pirogov Russian National Research Medical University Moscow Russia

3. Clinica de Occidente Santiago de Cali Colombia

4. Department of CardiologySarawak Heart Centre Kota Samarahan Malaysia

5. Department of Cardiac Sciences, King Fahad Cardiac CentreCollege of Medicine, King Saud University Riyadh Saudi Arabia

6. Oslo University Hospital Ullevål Norway

7. Penang Hospital Pulau Pinang Malaysia

8. Gregorio Marañón Hospital and Complutense University Madrid Spain

9. Mazankowski Alberta Heart Institute and University of Alberta Edmonton Alberta Canada

10. Fuwai Hospital Beijing China

11. South Australian Health and Medical Research InstituteFlinders University and Medical Centre Adelaide Australia